Litcius/Paper detail

Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid

Uday Zachariah, S C Nair, Ashish Goel, K.A. Balasubramanian, I. J. Mackie, Elwyn Elias, C. E. Eapen

2020Thrombosis Research38 citationsDOIOpen Access PDF

Topics & Concepts

MedicineVon Willebrand factorCoronavirus disease 2019 (COVID-19)Internal medicineCoagulopathyGastroenterologyDiseaseInfectious disease (medical specialty)PlateletCOVID-19 Clinical Research StudiesSepsis Diagnosis and TreatmentVenous Thromboembolism Diagnosis and Management
Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid | Litcius